These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 15374001)
1. Functional analysis of HIV-1 vif genes derived from Japanese long-term nonprogressors and progressors for AIDS. Sakurai A; Jere A; Yoshida A; Yamada T; Iwamoto A; Adachi A; Fujita M Microbes Infect; 2004 Jul; 6(9):799-805. PubMed ID: 15374001 [TBL] [Abstract][Full Text] [Related]
2. Nuclear localization of HIV type 1 Vif isolated from a long-term asymptomatic individual and potential role in virus attenuation. Farrow MA; Somasundaran M; Zhang C; Gabuzda D; Sullivan JL; Greenough TC AIDS Res Hum Retroviruses; 2005 Jun; 21(6):565-74. PubMed ID: 15989462 [TBL] [Abstract][Full Text] [Related]
3. Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group. Rhodes DI; Ashton L; Solomon A; Carr A; Cooper D; Kaldor J; Deacon N J Virol; 2000 Nov; 74(22):10581-8. PubMed ID: 11044102 [TBL] [Abstract][Full Text] [Related]
4. Genetic characterization of vif, vpr, and vpu sequences from long-term survivors of human immunodeficiency virus type 1 infection. Zhang L; Huang Y; Yuan H; Tuttleton S; Ho DD Virology; 1997 Feb; 228(2):340-9. PubMed ID: 9123841 [TBL] [Abstract][Full Text] [Related]
5. Characterization of human immunodeficiency virus type 1 vif gene in long-term asymptomatic individuals. Hassaïne G; Agostini I; Candotti D; Bessou G; Caballero M; Agut H; Autran B; Barthalay Y; Vigne R Virology; 2000 Oct; 276(1):169-80. PubMed ID: 11022005 [TBL] [Abstract][Full Text] [Related]
6. Inefficient enhancement of viral infectivity and CD4 downregulation by human immunodeficiency virus type 1 Nef from Japanese long-term nonprogressors. Tobiume M; Takahoko M; Yamada T; Tatsumi M; Iwamoto A; Matsuda M J Virol; 2002 Jun; 76(12):5959-65. PubMed ID: 12021328 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a two-amino-acid insertion in HIV-1 Vif from a nonprogressing mother and child. Alexander L; Aquino-DeJesus MJ; Chan M; Andiman WA J Virol; 2002 Oct; 76(20):10533-9. PubMed ID: 12239333 [TBL] [Abstract][Full Text] [Related]
8. The tyrosine kinase Hck is an inhibitor of HIV-1 replication counteracted by the viral vif protein. Hassaïne G; Courcoul M; Bessou G; Barthalay Y; Picard C; Olive D; Collette Y; Vigne R; Decroly E J Biol Chem; 2001 May; 276(20):16885-93. PubMed ID: 11278465 [TBL] [Abstract][Full Text] [Related]
9. In vivo genetic variability of the HIV-1 vif gene. Wieland U; Hartmann J; Suhr H; Salzberger B; Eggers HJ; Kühn JE Virology; 1994 Aug; 203(1):43-51. PubMed ID: 8030283 [TBL] [Abstract][Full Text] [Related]
10. The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2. Michaels FH; Hattori N; Gallo RC; Franchini G AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1025-30. PubMed ID: 8280477 [TBL] [Abstract][Full Text] [Related]
11. Genetic characterization of accessory genes from human immunodeficiency virus type 1 group O strains. Bibollet-Ruche F; Loussert-Ajaka I; Simon F; Mboup S; Ngole EM; Saman E; Delaporte E; Peeters M AIDS Res Hum Retroviruses; 1998 Jul; 14(11):951-61. PubMed ID: 9686641 [TBL] [Abstract][Full Text] [Related]
12. HIV accessory genes Vif and Vpu. Strebel K Adv Pharmacol; 2007; 55():199-232. PubMed ID: 17586316 [No Abstract] [Full Text] [Related]
13. Analysis of substitution events in HIV-1 vif gene of the Korean clade. Park CS; Kim MS; Yi HA; Lee DH; Lee KM; Lee CH J Microbiol; 2007 Feb; 45(1):75-8. PubMed ID: 17342060 [TBL] [Abstract][Full Text] [Related]
14. Comparison of proviral accessory genes between long-term nonprogressors and progressors of human immunodeficiency virus type 1 infection. Yamada T; Iwamoto A Arch Virol; 2000; 145(5):1021-7. PubMed ID: 10881687 [TBL] [Abstract][Full Text] [Related]
16. Recombinational analysis of a natural noncytopathic human immunodeficiency virus type 1 (HIV-1) isolate: role of the vif gene in HIV-1 infection kinetics and cytopathicity. Sakai K; Ma XY; Gordienko I; Volsky DJ J Virol; 1991 Nov; 65(11):5765-73. PubMed ID: 1920615 [TBL] [Abstract][Full Text] [Related]
17. Virion incorporation of human immunodeficiency virus type-1 Vif is determined by intracellular expression level and may not be necessary for function. Simon JH; Miller DL; Fouchier RA; Malim MH Virology; 1998 Sep; 248(2):182-7. PubMed ID: 9721227 [TBL] [Abstract][Full Text] [Related]
18. Conservation of an intact human immunodeficiency virus type 1 vif gene in vitro and in vivo. Sova P; van Ranst M; Gupta P; Balachandran R; Chao W; Itescu S; McKinley G; Volsky DJ J Virol; 1995 Apr; 69(4):2557-64. PubMed ID: 7884906 [TBL] [Abstract][Full Text] [Related]
19. Intravirion processing of the human immunodeficiency virus type 1 Vif protein by the viral protease may be correlated with Vif function. Khan MA; Akari H; Kao S; Aberham C; Davis D; Buckler-White A; Strebel K J Virol; 2002 Sep; 76(18):9112-23. PubMed ID: 12186895 [TBL] [Abstract][Full Text] [Related]
20. Expression of HIV-1 accessory protein Vif is controlled uniquely to be low and optimal by proteasome degradation. Fujita M; Akari H; Sakurai A; Yoshida A; Chiba T; Tanaka K; Strebel K; Adachi A Microbes Infect; 2004 Jul; 6(9):791-8. PubMed ID: 15374000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]